| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| NET VALUE OPTIONS | 6,051 | 2,685 |
| 102 BANK OF AMERICA | 3,263 | 2,897 |
| 200 CONAGRA | 7,104 | 6,468 |
| 100 FASTENAL | 5,950 | 5,926 |
| 120 FIBROCELL | 687 | 254 |
| 3 HELIOS AND MATHESON | 1,364 | |
| 200 IMMUNE DESIGN | 675 | 320 |
| 200 ROCKWELL | 1,365 | 662 |
| 100 VIKING THERAPEUTICS | 640 | 1,993 |
| Item No. | 1 |
|---|---|
| Lender's Name | TD AMERITRADE |
| Lender's Title | |
| Relationship to Insider | BROKERAGE FIRM |
| Original Amount of Loan | |
| Balance Due | 11,158 |
| Date of Note | |
| Maturity Date | |
| Repayment Terms | |
| Interest Rate | |
| Security Provided by Borrower | SECURITIES |
| Purpose of Loan | |
| Description of Lender Consideration | |
| Consideration FMV |
| Description | Amount |
|---|---|
| CAPITAL LOSSES | 5,497 |